Navigation Links
Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
Date:6/5/2008

Regado's lead product candidate, REG1, is the first specific, direct-acting, antidote-controlled anticoagulant ever described. Regado is developing REG1 for use in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures. These procedures, which include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), put patients at a high-risk for therapy-related bleeding complications. REG1 is being developed initially to increase therapeutic flexibility and improve patient outcomes in coronary revascularization procedures.

REG1 is a two-component system, consisting of an aptamer-based anticoagulant and its matched antidote. The REG1 anticoagulant component (RB006) is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits Factor IXa, a protein that is critical to blood coagulation. The antidote component, RB007, is a complementary nucleic acid that binds to and neutralizes RB006. The binding of RB007 to RB006 causes the predictable and rapid reversal of RB006 that allows the patient's blood to return to normal.

About Regado Biosciences

Regado Biosciences is pioneering a new therapeutic field with the discovery and development of drug:antidote systems. Regado's drug:antidote systems are designed to give physicians the ability to fine-tune the therapeutic effect desired for each patient and in each setting. A spin-out of the Department of Surgery at Duke University Medical Center, Regado was created to answer the therapeutic needs identified by its scientific founders.

The Company's proprietary platform technology enables the discovery of oligonucleotide-based drug-antidote pairs to any target protein. Regado initially is focusing its discovery and development efforts on the acute care injectable antithrombotics, a multi-billion dollar market in need of therapeutics with improved safety profiles. Potential future indications for Regado's
'/>"/>

SOURCE Regado Biosciences
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
2. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
3. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
4. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
5. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
6. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
7. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
8. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
9. Neurocrine Biosciences Reports First Quarter 2008 Results
10. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
11. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 27, 2015 BioLife Solutions , Inc. ... marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues ("BioLife" ... Food and Drug Administration has confirmed acceptance of the ... While not an endorsement nor approval of BioLife,s products ...
(Date:4/26/2015)... 2015 Cancer experts have reported how a ... in the area of distributed learning is helping to ... of patients. Speakers at a Varian-hosted symposium at the ... in Barcelona detailed the importance ... knowledge to help benefit the next patient. ...
(Date:4/24/2015)... , und BARCELONA ... (Stand Nr. 4410) iCAD, Inc. (Nasdaq: ... moderner Bildanalyse, Lösungen für Behandlungsabläufe und Strahlentherapie ... hat heute die sofortige Verfügbarkeit des ersten ... Brachytherapy (eBx ® ) System ® ...
Breaking Medicine Technology:BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 2BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 3BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 4Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 2Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 3Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 2Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 3Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 4Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 5Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 6
... May 22, 2012 Cephasonics, Inc., a ... and subsystems to the imaging and ultrasound markets, ... agreement with Tritech Ltd.  Tritech, a leading Israeli ... partner driving the success of Cephasonics, embedded-ultrasound product ...
... NEWTON, Mass., May 22, 2012  Halo Therapeutics, LLC, ... rare fibrotic diseases, announced today that it has ... foundations serving the muscular dystrophy patient community. Halo ... 2 study of HT-100, its lead drug candidate ...
Cached Medicine Technology:Cephasonics Inks Distribution Deal With Tritech To Extend Worldwide Sales Reach Into Israel 2Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 2Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 3
(Date:4/27/2015)... (PRWEB) April 27, 2015 Telematics Berlin ... tier 1&2 suppliers, associations, CE players and the government ... has opened to the car. This year’s panel on ... DG-Move at the European Commission, is an opportunity to ... and define a European Automotive Security Standard for years ...
(Date:4/27/2015)... 27, 2015 Attorney Dan Newlin, of the ... and protecting his clients, took that commitment to a whole ... code which makes it easier for existing and potential clients ... building his brand and added value to the firm’s services, ... area where Newlin has law offices. , “I knew the ...
(Date:4/27/2015)... Scooter Direct is now offering Pride ... price of only $929.00, marked down from the MSRP ... is known for offering quality mobility solutions to its ... wheel chairs, lift chairs, and their accessories at unbeatable ... of Go Go Traveller Elite, a senior store manager ...
(Date:4/27/2015)... On the top floor of the luxurious Beverly ... Los Angeles, CA, Per Wickstrom had an in-depth conversation ... of Orange County” Gretchen Christine Rossi. , In ... “Salute to the Oscars” celebration, sponsored by Choices Recovery, ... Wickstrom, Rossi felt that the evening’s interviews would not ...
(Date:4/27/2015)... Denver, Colorado (PRWEB) April 27, 2015 ... a ground-breaking solution to a problem that has ... marketing and advertising campaigns: by announcing the ... engine of its kind. , Officially launched ... industry and was created to index only marijuana-related ...
Breaking Medicine News(10 mins):Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 3Health News:Dan Newlin Hashtags It With #Dan 2Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 2Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 3Health News:Per Wickstrom Shares His Vision of Choices Recovery with Reality TV Star Gretchen Christine Rossi 2Health News:The WeedLife Network debuts its ground-breaking WeedLIVE cannabis industry search engine 2Health News:The WeedLife Network debuts its ground-breaking WeedLIVE cannabis industry search engine 3
... risk factor for active tuberculosis (TB) disease, according to a ... research analyzed data from nearly 17,000 individuals in Taiwan as ... While past studies have reported increased mortality among TB patients ... direct effect of smoking on active TB incidence using a ...
... ... professionals , ... August 23, 2009 -- An aging population and medical advances are a couple of ... (NRAF) is honoring the difference they make during the 2009 National Rehabilitation Awareness ...
... and methods, experts say simple CPR works best , SUNDAY, ... to participating in a flurry of activity when trying to ... IVs, placing a breathing tube, performing defibrillation to restart the ... advanced techniques saves lives as well as ordinary cardiopulmonary resuscitation, ...
... , LOUISVILLE, Ky., Aug. 22 A top medical ... Legion and colleague veterans service organizations can play a key role ... national suicide prevention coordinator, in pointing to the 5,000 self-inflicted deaths ... of our responsibility to own up to that. There,s no reason ...
... YouTube ... , ... August 22, 2009 -- Over 50 million American men suffer from hair loss. With that ... male pattern hair loss sufferer, Kevin Nalty (a.k.a. "Nalts") to raise awareness about hair loss ...
... Aug. 7, 2009 Dr. Glen Weiss of ... this week announced two significant advances in treating lung ... Weiss, M.D., an Associate Investigator in TGen,s Cancer and ... TGen Clinical Research Services at Scottsdale Healthcare, made both ...
Cached Medicine News:Health News:Smoking increases risk of developing active TB 2Health News:Smoking increases risk of developing active TB 3Health News:Medical Advances, Population Changes Fuel Demand for Rehabilitation Professionals 2Health News:It's Back to Basics to Save a Life 2Health News:It's Back to Basics to Save a Life 3Health News:The American Legion Can Play Key Role in Vets' Suicide Prevention, Says VA 2Health News:Vlogging For Hair: YouTube Star 'Nalts' Promotes Hair Loss Awareness with Dr. Alan Bauman 2Health News:Vlogging For Hair: YouTube Star 'Nalts' Promotes Hair Loss Awareness with Dr. Alan Bauman 3Health News:Vlogging For Hair: YouTube Star 'Nalts' Promotes Hair Loss Awareness with Dr. Alan Bauman 4Health News:Advances in lung cancer research announced at conference 2
Midstream Catch Kits...
... The BladderScan® is a portable, noninvasive ... is battery-operated, easy to use, and quickly ... minutes, you can use the BladderScan® to ... bladder volume. The BladderScan® supplies the information ...
... The Pediatric BladderScan® is ... Diagnostic Ultrasound's trusted family ... enabling healthcare providers to ... volume noninvasively, this easy-to-use, ...
... BVI 6300 Bladder Monitor is a ... the healthcare provider to enable patients ... ongoing basis. It is easy to ... so the patient can make informed ...
Medicine Products: